Marksans Pharma (BOM:524404) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524404 Marksans Pharma Ltd BOM:524404
86 GF Score
Price ₹267.10
GF Value ₹229.53
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Marksans Pharma Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:524404
86GF Score
Marksans Pharma Ltd BOM:524404
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Marksans Pharma (BOM:524404) Overvalued in 2026?

Based on GuruFocus' analysis, Marksans Pharma stock appears to be overvalued. The current stock price of ₹267.10 is trading 16.4% above its estimated GF Value™ of ₹229.53. GuruFocus considers Marksans Pharma to be Modestly Overvalued.

Key valuation signals for BOM:524404:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹229.53 vs. price of ₹267.10 (16.4% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the BOM:524404 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Marksans Pharma Business Description

Other Exchanges MARKSANS:India
Address Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.
86GF Score

Get the complete analysis for BOM:524404

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹267.10
Price
₹229.53
GF Value